PATIENTS’ PREFERENCES FOR TREATMENT OF HEPATITIS C

. Author manuscript; available in PMC: 2011 Jan 1.

Published in final edited form as: Med Decis Making. 2009 Jul 27;30(1):45–57. doi: 10.1177/0272989X09341588

No fibrosis - Genotype 1	Treated: The virus is cleared in 45 out of 100 patients. No one, whether or not the virus is cleared, has cirrhosis after 10 or more years.
	Not treated: The virus is not cleared; No one has cirrhosis after 10 or more years.
No fibrosis - Genotype 2	Treated: The virus is cleared in 80 out of 100 patients. No one, whether or not the virus is cleared, has cirrhosis after 10 or more years.
	Not treated: The virus is not cleared; No one has cirrhosis after 10 or more years.
Mild fibrosis - Genotype 1	Treated: The virus is cleared in 45 out of 100 patients. None of these patients have cirrhosis after 10 or more years.
	Not treated: The virus is not cleared; 10 out of 100 people have cirrhosis after 10 or more years.
Mild fibrosis - Genotype 2	Treated: The virus is cleared in 80 out of 100 patients. None of these patients have cirrhosis after 10 or more years.
	Not treated: The virus is not cleared; 10 out of 100 people have cirrhosis after 10 or more years.
Moderate fibrosis - Genotype 1	Treated: The virus is cleared in 45 out of 100 patients. None of these patients have cirrhosis after 10 or more years.
	Not treated: The virus is not cleared; 50 out of 100 people have cirrhosis after 10 or more years.
Moderate fibrosis - Genotype 2	Treated: The virus is cleared in 80 out of 100 patients. None of these patients have cirrhosis after 10 or more years.
	Not treated: The virus is not cleared; 50 out of 100 people have cirrhosis after 10 or more years.
Cirrhosis - Genotype 1	Treated: The virus is cleared in 30 out of 100 patients. The risk of having liver failure and liver cancer is MUCH lower in these patients.
	Not treated: The virus is not cleared. In 10 years, 40 out of 100 patients have liver failure and 7 out of 100 patients have liver cancer.
Cirrhosis - Genotype 2	Treated: The virus is cleared in 70 out of 100 patients. The risk of having liver failure and liver cancer is MUCH lower in these patients.
	Not treated: The virus is not cleared. In 10 years, 40 out of 100 patients have liver failure and 7 out of 100 patients have liver cancer.